Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility

被引:115
|
作者
Lio, Chan-Wang [1 ]
Zhang, Jiayuan [2 ,3 ]
Gonzalez-Avalos, Edahi [1 ]
Hogan, Patrick G. [1 ]
Chang, Xing [1 ,2 ,3 ,4 ]
Rao, Anjana [1 ,4 ,5 ,6 ]
机构
[1] Div Signaling & Gene Express, San Diego, CA USA
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
[4] Sanford Consortium Regenerat Med, San Diego, CA USA
[5] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA
[6] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA
来源
ELIFE | 2016年 / 5卷
基金
美国国家卫生研究院;
关键词
5-METHYLCYTOSINE OXIDATION; GENE-EXPRESSION; CELL IDENTITY; METHYLATION; PROTEINS; DIFFERENTIATION; ENHANCERS; ROLES; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION;
D O I
10.7554/eLife.18290
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ten-eleven translocation (TET) enzymes oxidize 5-methylcytosine, facilitating DNA demethylation and generating new epigenetic marks. Here we show that concomitant loss of Tet2 and Tet3 in mice at early B cell stage blocked the pro- to pre-B cell transition in the bone marrow, decreased Irf4 expression and impaired the germline transcription and rearrangement of the Ig kappa locus. Tet2/3-deficient pro-B cells showed increased CpG methylation at the Ig kappa 3' and distal enhancers that was mimicked by depletion of E2A or PU.1, as well as a global decrease in chromatin accessibility at enhancers. Importantly, re-expression of the Tet2 catalytic domain in Tet2/3-deficient B cells resulted in demethylation of the Igx enhancers and restored their chromatin accessibility. Our data suggest that TET proteins and lineage-specific transcription factors cooperate to influence chromatin accessibility and Igx enhancer function by modulating the modification status of DNA.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] Signatures of 5-methylcytosine modification in DNA by the tumor suppressor TET2
    Erlitzki, Noa
    Kohli, Rahul M.
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 353A - 354A
  • [42] Tet2 and Tet3 Mediated Active Cytosine Hydroxymethylation in Six2 Progenitor Cells Is Critical for Nephron Progenitor Differentiation and Nephron Endowment
    Liang, Xiujie
    Aranyi, Tamas
    Zhou, Jianfu
    Guan, Yuting
    Hu, Hailong
    Liu, Hongbo
    Susztak, Katalin
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 429 - 429
  • [43] Residual Wild-Type Tet2/Tet3 Allele Is the Savior Preventing Mouse Hematopoietic Progenitor Cells from Leukemia Development
    Shrestha, Raksha
    Koichiro, Maie
    Sakata-Yanagimoto, Mamiko
    Bernard, Olivier
    Matsui, Hirotaka
    Nakajima-Takagi, Yaeko
    Kato, Takayasu
    Koseki, Haruhiko
    Iwama, Atsushi
    Chiba, Shigeru
    BLOOD, 2018, 132
  • [44] TET2 and 3 proteins control iNKT cell lineage specification and TCR mediated expansion
    Tsagaratou, Ageliki
    Avalos, Edahi Gonzalez
    Rautio, Sini
    Browne, James Scott
    Togher, Susan
    Pastor, William
    Rothenberg, Ellen V.
    Landesmaki, Harri
    Rao, Anjana
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [45] TET enzymes regulate skeletal development through increasing chromatin accessibility of RUNX2 target genes
    Wang, Lijun
    You, Xiuling
    Ruan, Dengfeng
    Shao, Rui
    Dai, Hai-Qiang
    Shen, Weiliang
    Xu, Guo-Liang
    Liu, Wanlu
    Zou, Weiguo
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [46] TET enzymes regulate skeletal development through increasing chromatin accessibility of RUNX2 target genes
    Lijun Wang
    Xiuling You
    Dengfeng Ruan
    Rui Shao
    Hai-Qiang Dai
    Weiliang Shen
    Guo-Liang Xu
    Wanlu Liu
    Weiguo Zou
    Nature Communications, 13
  • [47] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?
    Song, Jinming
    Moscinski, Lynn
    Zhang, Hailing
    Zhang, Xiaohui
    Hussaini, Mohammad
    CANCER GENOMICS & PROTEOMICS, 2019, 16 (01) : 91 - 98
  • [48] Resistance to Inotuzumab Ozogamicin in a B-ALL Patient with TET2 and DNMT3A Mutations and Myeloid Lineage Switch
    Hergott, Christopher B.
    Kim, Annette S.
    Wadleigh, Martha
    Lindsley, R. Coleman
    BLOOD, 2018, 132
  • [49] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or Isolated TET2 Mutation?
    Song, Jimning
    Hussaini, Mohammad
    Talha, Rashid
    Zhang, Hailing
    Zhang, Ling
    Shao, Haipeng
    Zhang, Xiaohui
    Moscinski, Lynn
    MODERN PATHOLOGY, 2017, 30 : 379A - 379A
  • [50] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or Isolated TET2 Mutation?
    Song, Jinming
    Hussaini, Mohammad
    Talha, Rashid
    Zhang, Hailing
    Zhang, Ling
    Shao, Haipeng
    Zhang, Xiaohui
    Moscinski, Lynn
    LABORATORY INVESTIGATION, 2017, 97 : 379A - 379A